GSK plc Files Form 6-K on Share Transactions
Ticker: GLAXF · Form: 6-K · Filed: Jun 27, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, 6-K, disclosure
TL;DR
GSK plc filed a 6-K on 6/27/25 regarding share transactions.
AI Summary
GSK plc announced on June 27, 2025, a transaction involving its own shares. The filing is a Form 6-K, which is a report of a foreign private issuer required for significant events. The company's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Why It Matters
This filing indicates GSK plc is actively managing its share capital, which could impact share price and investor perception.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions by a foreign private issuer and does not contain immediate negative or positive financial news.
Key Players & Entities
- GSK plc (company) — Registrant
- 79 New Oxford Street, London, WC1A 1DG (location) — Principal executive office
- June 2025 (date) — Reporting period
- 20250627 (date) — Filing date
FAQ
What type of transaction did GSK plc announce on June 27, 2025?
GSK plc announced a 'Transaction in own shares'.
What is the filing type and its purpose?
The filing is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is GSK plc's principal executive office address?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
What is the SEC file number for GSK plc?
The SEC file number for GSK plc is 001-15170.
Does GSK plc file annual reports under Form 20-F or 40-F?
GSK plc indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 27, 2025 regarding GSK plc (GLAXF).